Fresenius Kabi introduces Vasopressin Injection, USP, in US
Pharma Leaders
JUNE 15, 2023
Bradycardia, tachyarrhythmias, decreased cardiac output, ischemia, and hyponatremia are some of the adverse reactions on using Vasopressin. Patients may also suffer from reversible diabetes insipidus after stopping treatment with vasopressin.
Let's personalize your content